BB Biotech AG
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BB Biotech AG's past years’ income statements indicate that its last revenue has increased compared to the previous period by 43% to -$199,567,000. The net income raised on -$206,607,000 and profit margin reached 104%. Total operating expenses were -$199,567,000.

Profit Margin

BB Biotech AG (SIX:BION.SW): Profit margin
2014 1.47B 1.47B 99.58%
2015 659.22M 652.81M 99.03%
2016 -796.44M -802.06M 100.71%
2017 693.05M 687.50M 99.2%
2018 -465.75M -471.34M 101.2%
2019 685.23M 677.43M 98.86%
2020 699.23M 691.17M 98.85%
2021 -396.22M -404.80M 102.17%
2022 -351.22M -357.81M 101.87%
2023 -199.56M -206.60M 103.53%

BION.SW Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
-199.56M-351.22M-396.22M699.23M685.23M-465.75M693.05M-796.44M659.22M1.47B
Cost of revenue
0000000000
Gross profit
-199.56M-351.22M-396.22M699.23M685.23M-465.75M693.05M-796.44M659.22M1.47B
Operating exp.
Research and development
0000000000
Selling and marketing
1.56M1.17M1.29M1.61M1.87M2.12M2.26M2.03M00
Total operating expenses
-199.56M6.52M8.52M7.98M7.73M5.51M5.47M5.54M6.33M6.17M
Operating income
-29.92M-356.02M-404.74M691.24M677.49M-470.18M688.12M-800.90M653.07M1.47B
Other income (expenses), net
-176.6M-1.72M-345.54M0-2.41M-1.08M-4.95M-1.08M-5.66M-4.40M
Income before tax
-206.52M-357.75M-404.74M691.24M677.49M-471.27M687.58M-801.99M652.89M1.47B
Income tax expense
79K61K67K75K68K71K77K71K80K78K
Net income
-206.60M-357.81M-404.80M691.17M677.43M-471.34M687.50M-802.06M652.81M1.47B
Earnings per share
Basic EPS
-3.77-6.5-7.3112.4812.23-8.5112.42-14.5111.6925.96
Diluted EPS
-3.77-6.46-7.3112.4812.23-8.5112.42-14.5111.6825.95
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source